期刊
CONTRACEPTION
卷 93, 期 1, 页码 65-69出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.contraception.2015.09.006
关键词
Combined oral contraceptives; Matrix metalloproteinase-2 (MMP-2); Matrix metalloproteinase-9 (MMP-9); Doxycycline; Endometrial biopsy
资金
- National Institute on Minority Health and Health Disparities of the National Institutes of Health [U54MD008149]
Objectives: To describe the effect of combined oral contraceptives (COCs) on matrix metalloproteinases MMP-2 and MMP-9 activity and compare MMP activity in women taking a COC with or without doxycycline. Study design: Subjects (n=20) underwent endometrial biopsies (1) in the late luteal phase of a baseline cycle prior to initiating COCs, (2) on days 19-21 while taking COCs in a standard 28-day cycle (7-day hormone-free interval) and (3) on days 26-28 while taking active COCs continuously for a 28-day cycle. During the continuous COC cycle, they were randomized to receive daily subantimicrobial dose doxycycline 40 mg or placebo. Results: Compared to baseline, COC treatment increased MMP-2 (p<.001) and MMP-9 (p<.001). MMP activity was lower in subjects taking a COC with doxycycline compared to those receiving placebo although only significantly lower for MMP-2 latent form (p=.002). Conclusions: Unscheduled bleeding with COCs may be the result of increased endometrial MMT's. Sample size limitations prevent us from determining how doxycycline affects MMP activity in COC users. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据